Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Remifentanil and Dexmedetomidine in Uterine Fibroid Ablation: a Comparative Study

NCT06640738 is registered in ClinicalTrials.gov with Kaohsiung Medical University as lead sponsor.

NCT NCT06640738
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06640738 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Remifentanil and Dexmedetomidine in Uterine Fibroid Ablation: a Comparative Study
Lead sponsor
Kaohsiung Medical University
Phase
Phase 4
Overall status
Not yet recruiting
Start date
October 1, 2024
Completion date
October 31, 2026
Enrollment
60 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

uterine fibroids (uf)